AURINIA PHARMACEUTICALS INC's ticker is and the CUSIP is 05156V902. A total of 4 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,177,932 | +34.5% | 151,600 | +67.5% | 0.00% | – |
| Q2 2023 | $876,040 | -70.5% | 90,500 | -66.6% | 0.00% | -100.0% |
| Q1 2023 | $2,965,776 | +289.8% | 270,600 | +53.7% | 0.00% | – |
| Q4 2022 | $760,752 | -65.5% | 176,100 | -39.9% | 0.00% | -100.0% |
| Q3 2022 | $2,203,000 | -67.2% | 292,900 | -56.2% | 0.00% | -66.7% |
| Q2 2022 | $6,721,000 | – | 668,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 617,600 | $4,644,000 | 0.01% |
| SIMPLEX TRADING, LLC | 234,900 | $1,766,000 | 0.00% |
| JANE STREET GROUP, LLC | 292,900 | $2,203,000 | 0.00% |
| JPMORGAN CHASE & CO | 87,300 | $656,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |